OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
-15.93%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$307M
AUM Growth
+$307M
(-26%)
Cap. Flow
-$40.3M
Cap. Flow
% of AUM
-13.12%
Top 10 Holdings %
Top 10 Hldgs %
66.99%
Holding
55
New
8
Increased
13
Reduced
15
Closed
15
Top Buys
| 1 |
TG Therapeutics
TGTX
|
$15.8M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
$14.1M |
| 3 |
Biodesix
BDSX
|
$3.04M |
| 4 |
Applied Therapeutics
APLT
|
$2.22M |
| 5 |
Ocular Therapeutix
OCUL
|
$2.16M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$14.1M |
| 2 |
TELA Bio
TELA
|
$6.64M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$6.21M |
| 4 |
Theravance Biopharma
TBPH
|
$5.63M |
| 5 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$5.57M |
Sector Composition
| 1 | Healthcare | 97.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cytokinetics
CYTK
$5.98B
| – | – |
-130,000
| Closed | -$4.24M |
|
52
Black Diamond Therapeutics
BDTX
$164M
| – | – |
-275,000
| Closed | -$1.39M |
|
53
Astria Therapeutics
ATXS
$394M
| – | – |
-305,000
| Closed | -$2.54M |
|
54
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-217,000
| Closed | -$5.2M |
|